VIVUS Total Assets 2006-2019 | VVUS

VIVUS total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
VIVUS Annual Total Assets
(Millions of US $)
2018 $302
2017 $265
2016 $306
2015 $277
2014 $367
2013 $432
2012 $264
2011 $152
2010 $144
2009 $230
2008 $208
2007 $199
2006 $78
2005 $49
VIVUS Quarterly Total Assets
(Millions of US $)
Q3 2019 $226
Q2 2019 $285
Q1 2019 $290
Q4 2018 $302
Q3 2018 $306
Q2 2018 $305
Q1 2018 $249
Q4 2017 $265
Q3 2017 $267
Q2 2017 $283
Q1 2017 $295
Q4 2016 $306
Q3 2016 $313
Q2 2016 $252
Q1 2016 $260
Q4 2015 $277
Q3 2015 $291
Q2 2015 $311
Q1 2015 $355
Q4 2014 $367
Q3 2014 $392
Q2 2014 $401
Q1 2014 $421
Q4 2013 $432
Q3 2013 $422
Q2 2013 $427
Q1 2013 $211
Q4 2012 $264
Q3 2012 $309
Q2 2012 $322
Q1 2012 $339
Q4 2011 $152
Q3 2011 $160
Q2 2011 $126
Q1 2011 $136
Q4 2010 $144
Q3 2010 $176
Q2 2010 $192
Q1 2010 $210
Q4 2009 $230
Q3 2009 $242
Q2 2009 $161
Q1 2009 $181
Q4 2008 $208
Q3 2008 $221
Q2 2008 $172
Q1 2008 $181
Q4 2007 $199
Q3 2007 $206
Q2 2007 $70
Q1 2007 $72
Q4 2006 $78
Q3 2006 $44
Q2 2006 $50
Q1 2006 $45
Q4 2005 $49
Q3 2005 $51
Q2 2005 $56
Q1 2005 $66
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.028B $0.065B
VIVUS is a biopharmaceutical company developing innovative, next-generation therapies to address unmet needs in obesity, diabetes and sexual health. The company's lead investigational product in clinical development, Qnexa(TM), is expected to complete Phase 3 clinical trials for the treatment of obesity in 2009. Qnexa is also in Phase 2 clinical development for the treatment of type 2 diabetes. In the area of sexual health, VIVUS is in Phase 3 development with avanafil, its PDE5 inhibitor drug candidate, and in Phase 2 development of Luramist(TM), its drug candidate for the treatment of hypoactive sexual desire disorder (HSDD) in women. MUSE(R) (alprostadil), a first generation therapy for the treatment of ED, is already on the market and generating revenue for VIVUS.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $134.042B 15.44
CSL (CSLLY) Australia $95.565B 0.00
Gilead Sciences (GILD) United States $79.894B 9.90
Vertex Pharmaceuticals (VRTX) United States $58.903B 60.12
Biogen (BIIB) United States $50.188B 8.61
Illumina (ILMN) United States $46.978B 51.54
Regeneron Pharmaceuticals (REGN) United States $37.910B 16.60
Alexion Pharmaceuticals (ALXN) United States $23.295B 11.51
Seattle Genetics (SGEN) United States $19.464B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.134B 0.00
Incyte (INCY) United States $16.530B 38.37
BioMarin Pharmaceutical (BMRN) United States $15.475B 0.00
Genmab (GNMSF) Denmark $14.016B 61.91
Alnylam Pharmaceuticals (ALNY) United States $13.379B 0.00
Galapagos (GLPG) Belgium $12.683B 32.68
Exact Sciences (EXAS) United States $11.629B 0.00
Bio-Rad Laboratories (BIO.B) United States $11.238B 53.94
BeiGene (BGNE) Cayman Islands $9.989B 0.00
Sarepta Therapeutics (SRPT) United States $8.378B 0.00
Bio-Techne Corp (TECH) United States $8.193B 54.84
BioNTech SE (BNTX) Germany $7.917B 0.00
QIAGEN (QGEN) Netherlands $7.884B 25.71
Guardant Health (GH) United States $7.516B 0.00
Amarin (AMRN) Ireland $7.223B 0.00
Moderna (MRNA) United States $7.038B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.754B 17.17
ACADIA Pharmaceuticals (ACAD) United States $6.059B 0.00
Reata Pharmaceuticals (RETA) United States $5.857B 0.00
Ascendis Pharma (ASND) Denmark $5.722B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.516B 0.00
Exelixis (EXEL) United States $5.475B 15.40
Repligen (RGEN) United States $5.160B 93.50
Bluebird Bio (BLUE) United States $4.828B 0.00
China Biologic Products (CBPO) China $4.540B 25.58
MorphoSys AG (MOR) Germany $4.157B 0.00
Adaptive Biotechnologies (ADPT) United States $3.799B 0.00
Mirati Therapeutics (MRTX) United States $3.588B 0.00
Immunomedics (IMMU) United States $3.535B 0.00
NeoGenomics (NEO) United States $3.372B 179.44
Ultragenyx Pharmaceutical (RARE) United States $3.291B 0.00
Blueprint Medicines (BPMC) United States $3.227B 0.00
MyoKardia (MYOK) United States $3.188B 0.00
Zai Lab (ZLAB) China $3.181B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.164B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.022B 0.00
Genmab (GMAB) Denmark $2.906B 5.99
Emergent Biosolutions (EBS) United States $2.892B 28.73
Halozyme Therapeutics (HALO) United States $2.795B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.790B 0.00
Alkermes (ALKS) Ireland $2.776B 0.00
Acceleron Pharma (XLRN) United States $2.763B 0.00
UniQure (QURE) Netherlands $2.710B 0.00
Denali Therapeutics (DNLI) United States $2.367B 0.00
Amicus Therapeutics (FOLD) United States $2.278B 0.00
Arena Pharmaceuticals (ARNA) United States $2.230B 5.19
RA PHARMCTL INC (RARX) United States $2.205B 0.00
Myriad Genetics (MYGN) United States $2.129B 31.45
Epizyme (EPZM) United States $2.040B 0.00
Principia Biopharma (PRNB) United States $1.876B 0.00
Zymeworks (ZYME) Canada $1.868B 0.00
Fate Therapeutics (FATE) United States $1.826B 0.00
Insmed (INSM) United States $1.795B 0.00
Akcea Therapeutics (AKCA) United States $1.700B 0.00
Alector (ALEC) United States $1.692B 0.00
Arvinas (ARVN) United States $1.690B 0.00
REGENXBIO (RGNX) United States $1.619B 0.00
Ligand Pharmaceuticals (LGND) United States $1.555B 29.91
Editas Medicine (EDIT) United States $1.454B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.318B 0.00
Intra-Cellular Therapies (ITCI) United States $1.308B 0.00
Zealand Pharma (ZLDPF) Denmark $1.292B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.276B 0.00
Coherus BioSciences (CHRS) United States $1.273B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.270B 0.00
Zealand Pharma (ZEAL) Denmark $1.153B 0.00
Athenex (ATNX) United States $1.111B 0.00
Mesoblast (MESO) Australia $1.060B 0.00
DBV Technologies S.A (DBVT) France $1.012B 0.00
Codexis (CDXS) United States $0.988B 0.00
Revance Therapeutics (RVNC) United States $0.982B 0.00
PHARMA MAR SA (PHMMF) Spain $0.945B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.937B 0.00
Pharming Group (PHGUF) Netherlands $0.909B 0.00
Sangamo Therapeutics (SGMO) United States $0.870B 0.00
Heska (HSKA) United States $0.813B 207.72
ZIOPHARM Oncology Inc (ZIOP) United States $0.800B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.762B 6.41
Vericel (VCEL) United States $0.752B 280.33
ANI Pharmaceuticals (ANIP) United States $0.744B 12.68
Adverum Biotechnologies (ADVM) United States $0.740B 0.00
GENFIT S.A (GNFT) France $0.729B 0.00
Twist Bioscience (TWST) United States $0.720B 0.00
Sorrento Therapeutics (SRNE) United States $0.717B 0.00
Cytokineticsorporated (CYTK) United States $0.710B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.708B 0.00
Retrophin (RTRX) United States $0.701B 0.00
Cellectis S.A (CLLS) France $0.696B 0.00
Intellia Therapeutics (NTLA) United States $0.675B 0.00
Cara Therapeutics (CARA) United States $0.642B 0.00
NantKwest (NK) United States $0.642B 0.00
UROGEN PHARMA (URGN) United States $0.636B 0.00
Anika Therapeutics (ANIK) United States $0.626B 20.32
AC Immune SA (ACIU) Switzerland $0.584B 13.50
Kadmon Holdings (KDMN) United States $0.580B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.568B 0.00
Prothena (PRTA) Ireland $0.523B 0.00
Agenus (AGEN) United States $0.519B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.515B 0.00
BioDelivery Sciences (BDSI) United States $0.515B 0.00
Precision BioSciences (DTIL) United States $0.504B 0.00
Clovis Oncology (CLVS) United States $0.489B 0.00
Bellus Health (BLU) Canada $0.487B 0.00
Dynavax Technologies (DVAX) United States $0.485B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Arcus Biosciences (RCUS) United States $0.430B 0.00
Inovio Pharmaceuticals (INO) United States $0.424B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.410B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.401B 0.00
Merus (MRUS) Netherlands $0.398B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.392B 0.00
Avid Bioservices (CDMO) United States $0.389B 0.00
AnaptysBio (ANAB) United States $0.380B 0.00
Kindred Biosciences (KIN) United States $0.371B 0.00
PDL BioPharma (PDLI) United States $0.371B 9.29
MannKind (MNKD) United States $0.363B 0.00
OSMOTICA PHARM (OSMT) United States $0.361B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.357B 2.47
Mersana Therapeutics (MRSN) United States $0.355B 0.00
Cue Biopharma (CUE) United States $0.350B 0.00
Gritstone Oncology (GRTS) United States $0.347B 0.00
CytomX Therapeutics (CTMX) United States $0.341B 0.00
Stemline Therapeutics (STML) United States $0.339B 0.00
Compugen (CGEN) Israel $0.339B 0.00
Cellular Biomedicine (CBMG) United States $0.330B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.327B 0.00
Puma Biotechnology (PBYI) United States $0.316B 0.00
Syros Pharmaceuticals (SYRS) United States $0.307B 0.00
Starpharma Holdings (SPHRY) Australia $0.304B 0.00
POXEL SA FRANCE (PXXLF) France $0.303B 0.00
Albireo Pharma (ALBO) United States $0.294B 0.00
IVERIC Bio (ISEE) United States $0.291B 0.00
Kamada (KMDA) Israel $0.273B 7.96
Geron (GERN) United States $0.272B 0.00
WAVE Life Sciences (WVE) Singapore $0.259B 0.00
Sutro Biopharma (STRO) United States $0.257B 0.00
ADMA Biologics Inc (ADMA) United States $0.253B 0.00
Biofrontera AG (BFRA) Germany $0.252B 0.00
Novavax (NVAX) United States $0.251B 0.00
ChromaDex (CDXC) United States $0.248B 0.00
Prometic Life Sciences (LMNL) Canada $0.245B 0.00
VBI Vaccines (VBIV) United States $0.228B 0.00
Affimed (AFMD) Germany $0.221B 0.00
Seres Therapeutics (MCRB) United States $0.219B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.214B 0.00
Theratechnologies (THTX) Canada $0.214B 0.00
Athersys (ATHX) United States $0.212B 0.00
Exicure (XCUR) United States $0.209B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.209B 0.00
Protagonist Therapeutics (PTGX) United States $0.205B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.204B 0.00
Cerecor (CERC) United States $0.203B 0.00
XOMA (XOMA) United States $0.203B 0.00
Five Prime Therapeutics (FPRX) United States $0.203B 0.00
Aptinyx (APTX) United States $0.195B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.191B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.190B 0.00
Spero Therapeutics (SPRO) United States $0.188B 0.00
Fortress Biotech (FBIO) United States $0.185B 0.00
Arbutus Biopharma (ABUS) Canada $0.180B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.178B 0.00
TELA Bio (TELA) United States $0.177B 0.00
Alcobra (ARCT) United States $0.177B 0.00
Strongbridge Biopharma (SBBP) United States $0.170B 4.54
Windtree Therapeutics (WINT) United States $0.161B 0.00
ARAVIVE, INC (ARAV) United States $0.157B 0.00
PHASEBIO PHARMA (PHAS) United States $0.152B 0.00
Selecta Biosciences (SELB) United States $0.148B 0.00
Dyadic (DYAI) United States $0.142B 0.00
Verastem (VSTM) United States $0.139B 0.00
Applied Genetic Technologies (AGTC) United States $0.135B 0.00
Abeona Therapeutics (ABEO) United States $0.135B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Menlo Therapeutics (MNLO) United States $0.134B 0.00
VTv Therapeutics (VTVT) United States $0.126B 0.00
Northwest Biotherapeutics (NWBO) United States $0.124B 0.00
Enzo Biochem (ENZ) United States $0.123B 0.00
Clearside Biomedical (CLSD) United States $0.123B 0.00
Liquidia Technologies (LQDA) United States $0.122B 0.00
Aduro Biotech (ADRO) United States $0.119B 0.00
Happiness Biotech Group (HAPP) China $0.118B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.117B 0.00
Arsanis (XFOR) United States $0.116B 0.00
OvaScience (MLND) United States $0.112B 0.00
Antibe Therapeutics (ATBPF) Canada $0.110B 0.00
Celyad SA (CYAD) Belgium $0.110B 0.00
Vaccinex (VCNX) United States $0.102B 0.00
Acorda Therapeutics (ACOR) United States $0.101B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.095B 0.00
SESEN BIO, INC (SESN) United States $0.093B 0.00
AIT Therapeutics (XAIR) United States $0.091B 0.00
Trevena (TRVN) United States $0.090B 0.00
Proteostasis Therapeutics (PTI) United States $0.089B 0.00
Adocia (ADOCY) France $0.086B 0.00
Synlogic (SYBX) United States $0.086B 0.00
Catalyst Biosciences (CBIO) United States $0.081B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.080B 0.00
Orgenesis (ORGS) United States $0.079B 5.10
Prima BioMed (IMMP) Australia $0.078B 0.00
Emmaus Life Sciences (EMMA) United States $0.075B 0.00
Checkpoint Therapeutics (CKPT) United States $0.072B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.071B 0.00
NewLink Genetics (NLNK) United States $0.068B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.068B 0.00
Soligenix (SNGX) United States $0.061B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.060B 0.00
Pluristem Therapeutics (PSTI) Israel $0.060B 0.00
Curis (CRIS) United States $0.056B 0.00
Idera Pharmaceuticals (IDRA) United States $0.054B 0.00
Vascular Biogenics (VBLT) Israel $0.053B 0.00
DiaMedica Therapeutics (DMAC) United States $0.050B 0.00
Organovo Holdings (ONVO) United States $0.048B 0.00
AquaBounty Technologies (AQB) United States $0.048B 0.00
Evogene (EVGN) Israel $0.044B 0.00
CollPlant Holdings (CLGN) Israel $0.041B 0.00
Alimera Sciences (ALIM) United States $0.037B 0.00
Celldex Therapeutics (CLDX) United States $0.037B 0.00
Entera Bio (ENTX) Israel $0.036B 0.00
Celsion (CLSN) United States $0.035B 0.00
VistaGen Therapeutics (VTGN) United States $0.034B 0.00
BioCardia (BCDA) United States $0.034B 0.00
Unum Therapeutics (UMRX) United States $0.033B 0.00
Pulmatrix (PULM) United States $0.032B 0.00
Signal Genetics (MGEN) United States $0.031B 0.00
Bionano Genomics (BNGO) United States $0.031B 0.00
Oncobiologics (OTLK) United States $0.029B 0.00
Aptevo Therapeutics (APVO) United States $0.029B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.027B 0.00
Novogen (KZIA) Australia $0.026B 0.00
AEterna Zentaris (AEZS) United States $0.024B 0.00
Stellar Biotechnologies (EDSA) Canada $0.023B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
Titan Pharmaceuticals (TTNP) United States $0.018B 0.00
Aytu Bioscience (AYTU) United States $0.017B 0.00
Advaxis (ADXS) United States $0.015B 0.00
Cleveland BioLabs (CBLI) United States $0.015B 0.00
Cesca Therapeutics (THMO) United States $0.014B 0.00
TOCAGEN INC (TOCA) United States $0.013B 0.00
TrovaGene (TROV) United States $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.004B 0.00